Categories Earnings, Industrials

Market expects updates on patent lawsuit in Digital Ally’s Q4 conference call

After reporting a decline in revenues and a narrower net loss for the fourth quarter of 2018, Digital Ally (DGLY) will be conducting a conference call at 11:15 am today. Analysts will be looking for updates on the company’s ongoing patent lawsuit with its rivals in the digital surveillance services sector.

Last month, Digital Ally said it received a favorable verdict in the patent case, with the US Patent Office rejecting a request by the complainants to invalidate its auto-activation patents. Considering the impact of the lawsuit on the company’s top-line performance in the recent quarters, any new update on the matter could influence the stock’s movement, which is currently trading lower.

Aso see: Digital Ally Q3 2018 Earnings Conference Call Transcript

Digital Ally reported the fourth quarter financial results on March 29, ahead of the scheduled release date, reporting a net loss of $5.3 million or $0.51 per share, compared to a loss of $4.4 million or $0.63 per share in the year-ago quarter. Revenues decreased 17% annually to about $2.4 million, while Selling, General and Administrative expenses increased by 37%.

Last month, Digital Ally said the US Patent Office rejected a request by the complainants in the lawsuit to invalidate its auto-activation patents

The management said Law Enforcement revenues declined year-over-year in the fourth quarter due to the willful infringement of the company’s patents by competitors, primarily Axon and WatchGuard, as well as adverse marketplace effects related to the litigation.

Currently, it is estimated that charges related to the ongoing litigation would continue to impact profitability during the rest of 2019, and probably beyond.

Digital Ally shares have gained 29% since the beginning of the year and 62% over the past twelve months. The stock closed the last session slightly down and traded lower in the early hours of Monday’s session.

 

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top